Legal & General Group’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.56M | Sell |
98,152
-934
| -0.9% | -$33.6K | ﹤0.01% | 1639 |
|
|
2026
Q1 | $2.43M | Sell |
99,086
-9,937
| -9% | -$235K | ﹤0.01% | 1838 |
|
|
2025
Q4 | $2.7M | Sell |
109,023
-6,432
| -6% | -$171K | ﹤0.01% | 1850 |
|
|
2025
Q3 | $3.27M | Sell |
115,455
-1,363
| -1% | -$36.9K | ﹤0.01% | 1772 |
|
|
2025
Q2 | $2.91M | Sell |
116,818
-4,751
| -4% | -$134K | ﹤0.01% | 1811 |
|
|
2025
Q1 | $3.77M | Sell |
121,569
-5,766
| -5% | -$192K | ﹤0.01% | 1655 |
|
|
2024
Q4 | $4.01M | Buy |
127,335
+1,973
| +2% | +$93.7K | ﹤0.01% | 1687 |
|
|
2024
Q3 | $7.26M | Buy |
125,362
+1,345
| +1% | +$66.1K | ﹤0.01% | 1369 |
|
|
2024
Q2 | $5.03M | Buy |
124,017
+3,161
| +3% | +$125K | ﹤0.01% | 1521 |
|
|
2024
Q1 | $5.07M | Buy |
120,856
+1,593
| +1% | +$62.1K | ﹤0.01% | 1511 |
|
|
2023
Q4 | $4.57M | Sell |
119,263
-1,696
| -1% | -$56.5K | ﹤0.01% | 1559 |
|
|
2023
Q3 | $3.73M | Buy |
120,959
+3,206
| +3% | +$111K | ﹤0.01% | 1600 |
|
|
2023
Q2 | $3.72M | Buy |
117,753
+20,729
| +21% | +$711K | ﹤0.01% | 1618 |
|
|
2023
Q1 | $3.54M | Sell |
97,024
-1,894
| -2% | -$66.3K | ﹤0.01% | 1604 |
|
|
2022
Q4 | $2.93M | Buy |
98,918
+3,275
| +3% | +$105K | ﹤0.01% | 1696 |
|
|
2022
Q3 | $3.73M | Buy |
95,643
+2,727
| +3% | +$125K | ﹤0.01% | 1523 |
|
|
2022
Q2 | $3.59M | Buy |
92,916
+2,408
| +3% | +$91.6K | ﹤0.01% | 1590 |
|
|
2022
Q1 | $4.39M | Sell |
90,508
-927
| -1% | -$47.8K | ﹤0.01% | 1583 |
|
|
2021
Q4 | $6.72M | Buy |
91,435
+3,161
| +4% | +$260K | ﹤0.01% | 1416 |
|
|
2021
Q3 | $8.04M | Buy |
88,274
+56,372
| +177% | +$4.79M | ﹤0.01% | 1288 |
|
|
2021
Q2 | $2.01M | Buy |
31,902
+28,032
| +724% | +$1.04M | ﹤0.01% | 1972 |
|
|
2021
Q1 | $105K | Buy |
3,870
+940
| +32% | +$22.6K | ﹤0.01% | 2607 |
|
|
2020
Q4 | $54K | Hold |
2,930
| – | – | ﹤0.01% | 2779 |
|
|
2020
Q3 | $53K | Buy |
2,930
+662
| +29% | +$11.4K | ﹤0.01% | 2680 |
|
|
2020
Q2 | $37K | Buy |
2,268
+380
| +20% | +$5.98K | ﹤0.01% | 2820 |
|
|
2020
Q1 | $25K | Sell |
1,888
-52
| -3% | -$848 | ﹤0.01% | 2837 |
|
|
2019
Q4 | $36K | Sell |
1,940
-3,243
| -63% | -$53.8K | ﹤0.01% | 2963 |
|
|
2019
Q3 | $92K | Buy |
5,183
+3,523
| +212% | +$60.3K | ﹤0.01% | 2549 |
|
|
2019
Q2 | $28K | Buy |
1,660
+549
| +49% | +$9.97K | ﹤0.01% | 3059 |
|
|
2019
Q1 | $20K | Hold |
1,111
| – | – | ﹤0.01% | 3096 |
|
|
2018
Q4 | $22K | Buy |
1,111
+603
| +119% | +$11.3K | ﹤0.01% | 3044 |
|
|
2018
Q3 | $11K | Sell |
508
-3,193
| -86% | -$67.2K | ﹤0.01% | 3316 |
|
|
2018
Q2 | $96K | Buy |
+3,701
| New | +$63.4K | ﹤0.01% | 2513 |
|
Other funds holding ASTH
3C
Legal & General Group's ASTH Position: Q2 2026 in Review
Legal & General Group reduced its Astrana Health (ASTH) stake by 0.94% in Q2 2026, selling an estimated $33.6K and leaving 98,152 shares worth $4.56M. The position accounts for ﹤0.01% of the portfolio, ranked #1639.
Legal & General Group first reported a position in ASTH in Q2 2018 and has held it in 33 quarters since. The position peaked at $8.04M in Q3 2021. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Legal & General Group held 98,152 shares of Astrana Health worth $4.56M as of Q2 2026.
- Legal & General Group sold 934 Astrana Health shares in Q2 2026, an estimated $33.6K.
- Astrana Health made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1639 holding.
- Legal & General Group first reported a position in Astrana Health in Q2 2018 and has held it in 33 quarters since.
- Legal & General Group's Astrana Health position peaked at $8.04M in Q3 2021.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.